Truist Financial Sticks to Their Buy Rating for Exponent (EXPO)

Truist Financial analyst Tobey Sommer maintained a Buy rating on Exponent (EXPO – Research Report) today. The company’s shares closed yesterday at $79.68.

Sommer covers the Industrials sector, focusing on stocks such as Waste Management, Exponent, and FTI Consulting. According to TipRanks, Sommer has an average return of 13.5% and a 65.89% success rate on recommended stocks.

Currently, the analyst consensus on Exponent is a Moderate Buy with an average price target of $82.00.

Based on Exponent’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $133.34 million and a net profit of $24.54 million. In comparison, last year the company earned a revenue of $127.18 million and had a net profit of $24.44 million

Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of EXPO in relation to earlier this year. Most recently, in February 2024, Richard Schlenker, the EVP & CFO of EXPO bought 5,648.00 shares for a total of $99,969.60.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Exponent (EXPO) Company Description:

Exponent, Inc. is an engineering and scientific consulting company, which engages in the provision of solutions. It operates through two segments: Engineering and Other Scientific; and Environmental and Health. The Engineering and Other Scientific segment provides technical consulting in different practices primarily in engineering. The Environmental and Health segment gives services in the area of environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1989 and is headquartered in Menlo Park, CA.